Guidance receptors in the nervous and cardiovascular systems

Biochemistry (Moscow)

Volumn 80, Issue 10, 2015, Pages 1235-1253

  Rubina, K A ^a   Tkachuk, V A ^a  

^a LOMONOSOV MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

angiogenesis; guidance receptors; neurogenesis; T cadherin; urokinase system

Indexed keywords

CELL SURFACE RECEPTOR;

ANIMAL; CARDIOVASCULAR SYSTEM; HUMAN; METABOLISM; NERVOUS SYSTEM;

ANIMALS; CARDIOVASCULAR SYSTEM; HUMANS; NERVOUS SYSTEM; RECEPTORS, CELL SURFACE;

EID: 84945183478     PISSN: 00062979     EISSN: 16083040     Source Type: Journal    
DOI: 10.1134/S0006297915100041     Document Type: Review

References (105)

1. Melani, M., and Weinstein, B. (2010) Common factors regulating patterning of the nervous and vascular systems, Annu. Rev. Cell Dev. Biol., 26, 639-665.
2. Carmeliet, P. (2003) Blood vessels and nerves: common sig-nals, pathways, and diseases, Nat. Rev. Genet., 4, 710-720.
3. Eichmann, A., Le Noble, F., Autiero, M., and Carmeliet, P. (2005) Neural guidance molecules regulate vascular remod-eling and vessel navigation, Genes Dev., 19, 1013-1021.
4. Weinstein, B. (2005) Vessels and nerves: marching to the same tune, Cel., 120, 299-302.
5. Bradshaw, R., and Dennis, E. (2010) Handbook of Cell Signaling, Elsevier/Academic Press, Amsterdam, pp. 443-449.
6. Poliakov, A., Cotrina, M., and Wilkinson, D. (2004) Diverse roles of Eph receptors and Ephrins in the regula-tion of cell migration and tissue assembly, Dev. Cel., 7, 465-480.
7. Pasquale, E. (2008) Eph-Ephrin bidirectional signaling in physiology and disease, Cel., 133, 38-52.
8. Pitulescu, M., and Adams, R. (2010) Eph/Ephrin mole-cules-a hub for signaling and endocytosis, Genes Dev., 24, 2480-2492.
9. Kuijper, S., Turner, C., and Adams, R. (2007) Regulation of angiogenesis by Eph-Ephrin interactions, Trends Cardiovasc. Med., 17, 145-151.
10. Palmer, A., and Klein, R. (2003) Multiple roles of Ephrins in morphogenesis, neuronal networking, and brain func-tion, Genes Dev., 17, 1429-1450.
11. Finne, E., Munthe, E., and Aasheim, H. (2004) A new Ephrin-A1 isoform (Ephrin-A1b) with altered receptor binding properties abrogates the cleavage of Ephrin-A1a, Biochem. J., 379, 39.
12. Santiago, A., and Erickson, C. (2002) Ephrin-B ligands play a dual role in the control of neural crest cell migration, Developmen., 129, 3621-3632.
13. Fagotto, F., Rohani, N., Touret, A., and Li, R. (2013) A molecular base for cell sorting at embryonic boundaries: contact inhibition of cadherin adhesion by Ephrin/Eph-dependent contractility, Dev. Cel., 27, 72-87.
14. Carmeliet, P., and Jain, R. (2011) Molecular mechanisms and clinical applications of angiogenesis, Natur., 473, 298-307.
15. Adams, R., and Eichmann, A. (2010) Axon guidance mol-ecules in vascular patterning, Cold Spring Harb. Perspect. Biol., 2, a001875.
16. Gerety, S., Wang, H., Chen, Z., and Anderson, D. (1999) Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand Ephrin-B2 in cardio-vascular development, Mol. Cel., 4, 403-414.
17. Larrivee, B., Freitas, C., Suchting, S., Brunet, I., and Eichmann, A. (2009) Guidance of vascular development: lessons from the nervous system, Circ. Res., 104, 428-441.
18. Kolodkin, A., Matthes, D., O'Connor, T., Patel, N., Admon, A., Bentley, D., and Goodman, C. (1992) Fasciclin IV: sequence, expression, and function during growth cone guidance in the grasshopper embryo, Neuro., 9, 831-845.
19. Luo, Y., Raible, D., and Raper, J. (1993) Collapsin: a pro-tein in brain that induces the collapse and paralysis of neu-ronal growth cones, Cel., 75, 217-227.
20. Ellis, L. (2006) The role of Neuropilins in cancer, Mol. Cancer Ther., 5, 1099-1107.
21. Bagri, A., Tessier-Lavigne, M., and Watts, R. (2009) Neuropilins in tumor biology, Clin. Cancer Res., 15, 1860-1864.
22. Appleton, B., Wu, P., Maloney, J., Yin, J., Liang, W., Stawicki, S., Mortara, K., Bowman, K., Elliott, J., Desmarais, W., Bazan, J., Bagri, A., Tessier-Lavigne, M., Koch, A., Wu, Y., Watts, R., and Wiesmann, C. (2007) Structural studies of Neuropilin/antibody complexes pro-vide insights into Semaphorin and VEGF binding, EMBO J., 26, 4902-4912.
23. Prahst, C., Heroult, M., Lanahan, A., Uziel, N., Kessler, O., Shraga-Heled, N., Simons, M., Neufeld, G., and Augustin, H. (2008) Neuropilin-1-VEGFR-2 complexing requires the PDZ-binding domain of Neuropilin-1, J. Biol. Chem., 283, 25110-25114.
24. Parker, M., Xu, P., Guo, H., and Vander Kooi, C. (2012) Mechanism of selective VEGF-A binding by Neuropilin-1 reveals a basis for specific ligand inhibition, PLoS One, 7, e49177.
25. Hedgecock, E., Culotti, J., and Hall, D. (1990) The unc-5, unc-6, and unc-40 genes guide circumferential migrations of pioneer axons and mesodermal cells on the epidermis in C. elegans, Neuro., 4, 61-85.
26. Leong, D., Hutmacher, D., Chew, F., and Lim, T. (2005) Viability and adipogenic potential of human adipose tissue processed cell population obtained from pump-assisted and syringe-assisted liposuction, J. Dermatol. Sci., 37, 169-176.
27. Wilson, B., Ii, M., Park, K. W., Suli, A., Sorensen, L. K., Larrieu-Lahargue, F., Urness, L. D., Suh, W., Asai, J., Kock, G. A., Thorne, T., Silver, M., Thomas, K. R., Chien, C. B., Losordo, D. W., and Li, D. Y. (2006) Netrins pro-mote developmental and therapeutic angiogenesis, Scienc., 313, 640-644.
28. Nguyen, A., and Cai, H. (2006) Netrin-1 induces angio-genesis via a DCC-dependent ERK1/2-eNOS feed-for-ward mechanism, Proc. Natl. Acad. Sci. US., 103, 6530-6535.
29. Park, K., Crouse, D., Lee, M., Karnik, S., Sorensen, L., Murphy, K., Kuo, C., and Li, D. (2004) The axonal attrac-tant Netrin-1 is an angiogenic factor, Proc. Natl. Acad. Sci. US., 101, 16210-16215.
30. Yang, Y., Zou, L., Wan, Y., Xu, K., Zhang, J., and Zhang, J. (2007) Axon guidance cue Netrin-1 has dual function in angiogenesis, Cancer Biol. Ther., 6, 743-748.
31. Hoang, S., Liauw, J., Choi, M., Choi, M., Guzman, R., and Steinberg, G. (2008) Netrin-4 enhances angiogenesis and neurologic outcome after cerebral ischemia, J. Cereb. Blood Flow Metab., 29, 385-397.
32. Jones, C., Nishiya, N., London, N., Zhu, W., Sorensen, L., Chan, A., Lim, C., Chen, H., Zhang, Q., Schultz, P., Hayallah, A., Thomas, K., Famulok, M., Zhang, K., Ginsberg, M., and Li, D. (2009) Slit2-Robo4 signalling promotes vascular stability by blocking Arf6 activity, Nat. Cell Biol., 11, 1325-1331.
33. Suchting, S., Heal, P., Tahtis, K., Stewart, L., and Bicknell, R. (2005) Soluble Robo4 receptor inhibits in vivo angiogen-esis and endothelial cell migration, FASEB J., 19, 121-123.
34. Wang, B., Xiao, Y., Ding, B., Zhang, N., Yuan, X., Gui, L., Qian, K., Duan, S., Chen, Z., Rao, Y., and Geng, J. (2003) Induction of tumor angiogenesis by Slit-Robo signaling and inhibition of cancer growth by blocking Robo activity, Cancer Cel., 4, 19-29.
35. Park, K., Morrison, C., Sorensen, L., Jones, C., Rao, Y., Chien, C., Wu, J., Urness, L., and Li, D. (2003) Robo4 is a vascular-specific receptor that inhibits endothelial migra-tion, Dev. Biol., 261, 251-267.
36. Jones, B., and McTaggart, S. (2008) Immunosuppression by mesenchymal stromal cells: from culture to clinic, Exp. Hematol., 36, 733-741.
37. Collen, D. (1999) The plasminogen (fibrinolytic) system, Thromb. Haemost., 82, 259-270.
38. Clowes, A., Clowes, M., Au, Y., Reidy, M., and Belin, D. (1990) Smooth muscle cells express urokinase during mito-genesis and tissue-type plasminogen activator during migration in injured rat carotid artery, Circ. Res., 67, 61-67.
39. Tkachuk, V., Stepanova, V., Little, P., and Bobik, A. (1996) Regulation and role of urokinase plasminogen activator in vascular remodeling, Clin. Exp. Pharmacol. Physiol., 23, 759-765.
40. Parfyonova, Y., Plekhanova, O., and Tkachuk, V. (2002) Plasminogen activators in vascular remodeling and angio-genesis, Biochemistry (Moscow., 67, 119-134.
41. Tkachuk, V. A., Plekhanova, O. S., Beloglazova, I. B., and Parfenova, E. V. (2013) A role of multi-domain structure of urokinase in regulating vascular growth and remodeling, Ukr. Biokhim. Zh., 85, 18-45.
42. Lijnen, H., Van Hoef, B., Nelles, L., and Collen, D. (1990) Plasminogen activation with single-chain urokinase-type plasminogen activator (scu-PA). Studies with active site mutagenized plasminogen (Ser740-Ala) and plasmin-resistant scu-PA (Lys158-Glu), J. Biol. Chem., 265, 5232-5236.
43. Rubina, K. A., and Tkachuk, V. A. (2004) Antiadhesive molecule T-cadherin is an atypical low-density lipoprotein receptor in vascular cells, Russ. Physiol. J., 90, 968-986.
44. Bobik, A., and Tkachuk, V. (2003) Metalloproteinases and plasminogen activators in vessel remodeling, Curr. Hypertens. Rep., 5, 466-472.
45. Naldini, L., Tamagnone, L., Vigna, E., Sachs, M., Hartmann, G., Birchmeier, W., Daikuhara, Y., Tsubouchi, H., Blasi, F., and Comoglio, P. (1992) Extracellular proteo-lytic cleavage by urokinase is required for activation of hepa-tocyte growth factor/scatter factor, EMBO J., 11, 4825-4833.
46. Plouet, J., Moro, F., Bertagnolli, S., Coldeboeuf, N., Mazarguil, H., Clamens, S., and Bayard, F. (1997) Extracellular cleavage of the vascular endothelial growth factor 189-amino acid form by urokinase is required for its mitogenic effect, J. Biol. Chem., 272, 13390-13396.
47. Saksela, O., and Rifkin, D. B. (1990) Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteo-lytic activity, J. Cell Biol., 110, 767-775.
48. Kuzuya, M., and Iguchi, A. (2003) Role of matrix metallo-proteinases in vascular remodeling, J. Atheroscler. Thromb., 10, 275-282.
49. Lamalice, L., Le Boeuf, F., and Huot, J. (2007) Endothelial cell migration during angiogenesis, Circ. Res., 100, 782-794.
50. Carmeliet, P., Heymans, S., Luttun, A., Nuyens, D., Theilmeier, G., Creemers, E., Moons, L., Dyspersin, G., Cleutjens, J., Shipley, M., Angellilo, A., Levi, M., Nube, O., Baker, A., Keshet, E., Lupu, F., Herbert, J., Smits, J., Shapiro, S., Baes, M., Borgers, M., Collen, D., and Daemen, M. (1999) Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure, Nat. Med., 5, 1135-1142.
51. Noh, H., Hong, S., and Huang, S. (2013) Role of uroki-nase receptor in tumor progression and development, Theranostic., 3, 487-495.
52. Odekon, L., Sato, Y., and Rifkin, D. (1992) Urokinase-type plasminogen activator mediates basic fibroblast growth factor-induced bovine endothelial cell migration independ-ent of its proteolytic activity, J. Cell. Physiol., 150, 258-263.
53. Okada, S., Grobmyer, S., and Barnathan, E. (1996) Contrasting effects of plasminogen activators, urokinase receptor, and LDL receptor B related protein on smooth muscle cell migration and invasion, Arterioscler. Thromb. Vasc. Biol., 16, 1269-1276.
54. Busso, N., Masur, S., Lazega, D., Waxman, S., and Ossowski, L. (1994) Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells, J. Cell Biol., 126, 259-270.
55. Resnati, M., Pallavicini, I., Wang, J., Oppenheim, J., Serhan, C., Romano, M., and Blasi, F. (2002) The fibri-nolytic receptor for urokinase activates the G protein-cou-pled chemotactic receptor FPRL1/LXA4R, Proc. Natl. Acad. Sci. US., 99, 1359-1364.
56. Dumler, I., Stepanova, V., Jerke, U., Mayboroda, O., Vogel, F., Bouvet, P., Tkachuk, V., Haller, H., and Gulba, D. (1999) Urokinase-induced mitogenesis is mediated by casein kinase 2 and nucleolin, Curr. Biol., 9, 1468-1476.
57. Parfenova, E. V., Plekhanova, O. S., Men'shikov, M. Iu., Stepanova, V. V., and Tkachuk, V. A. (2009) Regulation of grows and remodeling of blood vessels: the unique role of urokinase, Russ. Physiol. J., 95, 442-464.
58. Bohuslav, J., Horejsi, V., Hansmann, C., Stockl, J., Weidle, U., Majdic, O., Bartke, I., Knapp, W., and Stockinger, H. (1995) Urokinase plasminogen activator receptor, ß2-inte-grins, and Src-kinases within a single receptor complex of human monocytes, J. Exp. Med., 181, 1381-1390.
59. Blasi, F., and Carmeliet, P. (2002) uPAR: a versatile sig-nalling orchestrator, Nat. Rev. Mol. Cell Biol., 3, 932-943.
60. Sitrin, R., Pan, P., Harper, H., Todd, R., Harsh, D., and Blackwood, R. (2000) Clustering of urokinase receptors (uPAR; CD87) induces proinflammatory signaling in human polymorphonuclear neutrophils, J. Immunol., 165, 3341-3349.
61. Ghosh, S., Brown, R., Jones, J., Ellerbroek, S., and Stack, M. (2000) Urinary-type plasminogen activator (uPA) expression and uPA receptor localization are regulated by a3ß1 integrin in oral keratinocytes, J. Biol. Chem., 275, 23869-23876.
62. Kapustin, A., Stepanova, V., Aniol, N., Cines, D., Poliakov, A., Yarovoi, S., Lebedeva, T., Wait, R., Ryzhakov, G., Parfyonova, Y., Gursky, Y., Yanagisawa, H., Minashkin, M., Beabealashvilli, R., Vorotnikov, A., Bobik, A., and Tkachuk, V. (2012) Fibulin-5 binds urokinase-type plasminogen acti-vator and mediates urokinase-stimulated ß1-integrin-dependent cell migration, Biochem. J., 443, 491-503.
63. Traktuev, D., Tsokolaeva, Z., Shevelev, A., Talitskiy, K., Stepanova, V., Johnstone, B., Rahmat-Zade, T., Kapustin, A., Tkachuk, V., March, K., and Parfyonova, Y. (2007) Urokinase gene transfer augments angiogenesis in ischemic skeletal and myocardial muscle, Mol. Ther., 15, 1939-1946.
64. Uhrin, P., and Breuss, J. (2013) uPAR: a modulator of VEGF-induced angiogenesis, Cell Adh. Migr., 7, 23-26.
65. Prager, G., Breuss, J., Steurer, S., Mihaly, J., and Binder, B. (2004) Vascular endothelial growth factor (VEGF) induces rapid prourokinase (pro-uPA) activation on the surface of endothelial cells, Bloo., 103, 955-962.
66. Plekhanova, O., Parfyonova, Y., Bibilashvily, R., Stepanova, V., Erne, P., Bobik, A., and Tkachuk, V. (2000) Urokinase plasminogen activator enhances neointima growth and reduces lumen size in injured carotid arteries, J. Hypertens., 18, 1065-1069.
67. Plekhanova, O., Parfyonova, Y., Bibilashvily, R., Domogatskii, S., Stepanova, V., Gulba, D., Agrotis, A., Bobik, A., and Tkachuk, V. (2001) Urokinase plasminogen activator augments cell proliferation and neointima forma-tion in injured arteries via proteolytic mechanisms, Atherosclerosi., 159, 297-306.
68. Plekhanova, O., Berk, B., Bashtrykov, P., Brooks, A., Tkachuk, V., and Parfyonova, Y. (2009) Oligonucleotide microarrays reveal regulated genes related to inward arteri-al remodeling induced by urokinase plasminogen activator, J. Vasc. Res., 46, 177-187.
69. Parfyonova, Y., Plekhanova, O., Solomatina, M., Naumov, V., Bobik, A., Berk, B., and Tkachuk, V. (2004) Contrasting effects of urokinase and tissue-type plasminogen activators on neointima formation and vessel remodelling after arteri-al injury, Dement. Geriatr. Cogn. Disord., 41, 268-276.
70. Mekkawy, A., Pourgholami, M., and Morris, D. (2014) Involvement of urokinase-type plasminogen activator sys-tem in cancer: an overview, Med. Res. Rev., 34, 918-956.
71. George, S., and Beeching, C. (2006) Cadherin-catenin complex: a novel regulator of vascular smooth muscle cell behavior, Atherosclerosi., 188, 1-11.
72. Gumbiner, B. (2005) Regulation of cadherin-mediated adhesion in morphogenesis, Nat. Rev. Mol. Cell Biol., 6, 622-634.
73. Vestal, D., and Ranscht, B. (1992) Glycosyl phosphatidyl-inositol-anchored T-cadherin mediates calcium-depend-ent, homophilic cell adhesion, J. Cell Biol., 119, 451-461.
74. Ranscht, B., and Dours-Zimmermann, M. (1991) T-cad-herin, a novel cadherin cell adhesion molecule in the nerv-ous system lacks the conserved cytoplasmic region, Neuro., 7, 391-402.
75. Fredette, B., Miller, J., and Ranscht, B. (1996) Inhibition of motor axon growth by T-cadherin substrata, Developmen., 122, 3163-3171.
76. Fredette, B., and Ranscht, B. (1994) T-cadherin expression delineates specific regions of the developing motor axon-hindlimb projection pathway, J. Neurosci., 14, 7331-7346.
77. Teillet, M., Kalcheim, C., and Le Douarin, N. (1987) Formation of the dorsal root ganglia in the avian embryo: segmental origin and migratory behavior of neural crest progenitor cells, Dev. Biol., 120, 329-347.
78. Ranscht, B., and Bronner-Fraser, M. (1991) T-cadherin expression alternates with migrating neural crest cells in the trunk of the avian embryo, Developmen., 111, 15-22.
79. Takeuchi, T., Misaki, A., Liang, S., Tachibana, A., Hayashi, N., Sonobe, H., and Ohtsuki, Y. (2000) Expression of T-cad-herin (CDH13, H-cadherin) in human brain and its charac-teristics as a negative growth regulator of epidermal growth factor in neuroblastoma cells, J. Neurochem., 74, 1489-1497.
80. Philippova, M., Joshi, M., Kyriakakis, E., Pfaff, D., Erne, P., and Resink, T. (2009) A guide and guard: the many faces of T-cadherin, Cell. Signal., 21, 1035-1044.
81. Rubina, K. A., Smutova, V. A., Semenova, M. L., Poliakov, A. A., Gerety, S., Wilkinson, D., Surkova, E. I., Semina, E. V., Sysoeva, V. Y., and Tkachuk, V. A. (2015) Detection of T-cad-herin expression in mouse embryons, Acta Natura., 7, 87-94.
82. Rubina, K., Kalinina, N., Potekhina, A., Efimenko, A., Semina, E., Poliakov, A., Wilkinson, D., Parfyonova, Y., and Tkachuk, V. (2007) T-cadherin suppresses angiogene-sis in vivo by inhibiting migration of endothelial cells, Angiogenesi., 10, 183-195.
83. Ivanov, D., Philippova, M., Antropova, J., Gubaeva, F., Iljinskaya, O., Tararak, E., Bochkov, V., Erne, P., Resink, T., and Tkachuk, V. (2001) Expression of cell adhesion molecule T-cadherin in the human vasculature, Histochem. Cell Biol., 115, 231-242.
84. Kudrjashova, E., Bashtrikov, P., Bochkov, V., Parfyonova, Y., Tkachuk, V., Antropova, J., Iljinskaya, O., Tararak, E., Erne, P., Ivanov, D., Philippova, M., and Resink, T. (2002) Expression of adhesion molecule T-cadherin is increased during neointima formation in experimental restenosis, Histochem. Cell Biol., 118, 281-290.
85. Folkman, J. (2008) Tumor Angiogenesis, Springer, Berlin, pp. 3-28.
86. Cao, Y., Sun, Z., Liao, L., Meng, Y., Han, Q., and Zhao, R. (2005) Human adipose tissue-derived stem cells differ-entiate into endothelial cells in vitro and improve postnatal neovascularization in vivo, Biochem. Biophys. Res. Commun., 332, 370-379.
87. Andreeva, A., and Kutuzov, M. (2010) Cadherin 13 in can-cer, Genes Chromosomes Cance., 49, 775-790.
88. Wyder, L., Vitaliti, A., Schneider, H., Hebbard, L. W., Moritz, D. R., Wittmer, M., Ajmo, M., and Klemenz, R. (2000) Increased expression of H/T-cadherin in tumor-penetrating blood vessels, Cancer Res., 60, 4682-4688.
89. Takeuchi, T., and Ohtsuki, Y. (2001) Recent progress in T-cadherin (CDH13, H-cadherin) research, Histol. Histopathol., 16, 1287-1293.
90. Takeuchi, T., Liang, S. B., and Ohtsuki, Y. (2002) Downregulation of expression of a novel cadherin mole-cule, T-cadherin, in basal cell carcinoma of the skin, Mol. Carcinog., 35, 173-179.
91. Riener, M., Nikolopoulos, E., Herr, A., Wild, P., Hausmann, M., Wiech, T., Orlowska-Volk, M., Lassmann, S., Walch, A., and Werner, M. (2008) Microarray compar-ative genomic hybridization analysis of tubular breast carci-noma shows recurrent loss of the CDH13 locus on 16q, Hum. Pathol., 39, 1621-1629.
92. Sato, M., Mori, Y., Sakurada, A., Fujimura, S., and Horii, A. (1998) The H-cadherin (CDH13) gene is inactivated in human lung cancer, Hum. Genet., 103, 96-101.
93. Maruyama, R., Toyooka, S., Toyooka, K., Harada, K., Virmani, A., Zochbauer-Muller, S., Farinas, A., Vakar-Lopez, F., Minna, J., Sagalowsky, A., Czerniak, B., and Gazdar, A. (2001) Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features, Cancer Res., 61, 8659-8663.
94. Widschwender, M., Siegmund, K., Muller, H., Fiegel, H., Marth, C., Muller-Holzner, E., Jones, P., and Laird, P. (2004) Association of breast cancer DNA methylation pro-files with hormone receptor status and response to tamoxi-fan, Cancer Res., 64, 3807-3813.
95. Suehiro, Y., Okada, T., Okada, T., Anno, K., Okayama, N., Ueno, K., Hiura, M., Nakamura, M., Kondo, T., Oga, A., Kawauchi, S., Hirabayashi, K., Numa, F., Ito, T., Saito, T., Sasaki, K., and Hinoda, Y. (2008) Aneuploidy predicts outcome in patients with endometrial carcinoma and is related to lack of CDH13 hypermethylation, Clin. Cancer Res., 14, 3354-3361.
96. Zucchini, C., Bianchini, M., Valvassori, L., Perdichizzi, S., Benini, S., Manara, M., Solmi, R., Strippoli, P., Picci, P., Carinci, P., and Scotlandi, K. (2004) Identification of can-didate genes involved in the reversal of malignant phenotype of osteosarcoma cells transfected with the liver/bone/kidney alkaline phosphatase gene, Bon., 34, 672-679.
97. Rubina, K., Khlebnikova, A., Semina, E., Yurlova, E., Kalinina, N., Sysoeva, V., and Molochkov, V. (2012) Malignant transformation in skin is associated with the loss of T-cadherin expression in human keratinocytes and heterogeneity in T-cadherin expression in tumor vascu-lature, in Tumor Angiogenesis, InTech, Rijeka, pp. 135-166.
98. Rubina, K., Kalinina, N., Bochkov, V., Parfyonova, Y., and Tkachuk, V. (2005) T-cadherin as an antiadhesive and guidance molecule interacting with low-density lipopro-teins, Ann. Eur. Acad. Sci., pp. 1-14.
99. Kawakami, M., Staub, J., Cliby, W., Hartmann, L., Smith, D., and Shridhar, V. (1999) Involvement of H-cadherin (CDH13) on 16q in the region of frequent deletion in ovarian cancer, Int. J. Oncol., 15, 715-720.
100. Takeuchi, T., Liang, S., Matsuyoshi, N., Zhou, S., Miyachi, Y., Sonobe, H., and Ohtsuki, Y. (2002) Loss of T-cadherin (CDH13, H-cadherin) expression in cuta-neous squamous cell carcinoma, Lab. Invest., 82, 1023-1029.
101. Hibi, K., Nakayama, H., Kodera, Y., Ito, K., Akiyama, S., and Nakao, A. (2004) CDH13 promoter region is specifi-cally methylated in poorly differentiated colorectal cancer, Br. J. Cance., 90, 1030-1033.
102. Sakai, M., Hibi, K., Koshikawa, K., Inoue, S., Takeda, S., Kaneko, T., and Nakao, A. (2004) Frequent promoter methylation and gene silencing of CDH13 in pancreatic cancer, Cancer Sci., 95, 588-591.
103. Kim, S., J., Han, J., Shim, Y., Park, J., and Kim, D. (2005) Aberrant methylation of H-cadherin (CDH13) promoter is associated with tumor progression in primary nonsmall cell lung carcinoma, Cance., 104, 1825-1833.
104. Mukoyama, Y., Zhou, S., Miyachi, Y., and Matsuyoshi, N. (2005) T-cadherin negatively regulates the proliferation of cutaneous squamous carcinoma cells, J. Invest. Dermatol., 124, 833-838.
105. Yurlova, E., Rubina, K., Sysoeva, V., Sharonov, G., Semina, E., Parfenova, E., and Tkachuk, V. (2010) T-cad-herin suppresses the cell proliferation of mouse melanoma B16F10 and tumor angiogenesis in the model of chorioal-lantoic membrane, Russ. J. Dev. Biol., 41, 217-226.